Aug 7, 2026
New Research Reveals Ferroptosis Vulnerability in FLT3-Mutated Acute Myeloid Leukemia, Advancing Treatment Options
A Nature Cell Biology study identifies a novel therapeutic vulnerability in acute myeloid leukemia with FLT3 mutations, showing that FLT3 inhibitors trigger ferroptosis in cancer cells. The findings complement ongoing advances in FLT3-ITD+ AML treatment, including improved minimal residual disease testing and updated clinical practice guidelines.
3 sources
00